AREWX
Price
$27.66
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

AREWX vs VGSNX

Header iconAREWX vs VGSNX Comparison
Open Charts AREWX vs VGSNXBanner chart's image
American Century Real Estate R
Price$27.66
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AREWX vs VGSNX Comparison Chart
Loading...
VS
AREWX vs. VGSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AREWX is a Buy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. AREWX (744M). VGSNX pays higher dividends than AREWX: VGSNX (4.01) vs AREWX (1.82). AREWX was incepted earlier than VGSNX: AREWX (17 years) vs VGSNX (21 years). AREWX is a more actively managed with annual turnover of: 117.00 vs. VGSNX (9.00). AREWX has a lower initial minimum investment than VGSNX: AREWX (2500) vs VGSNX (5000000). VGSNX (26.90) and AREWX (25.62) have marching annual gain over last year. VGSNX return over 5 years is better than : 26.84 vs. AREWX (-5.51).
AREWXVGSNXAREWX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years21 years-
Gain YTD14.02013.452104%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets744M70.5B1%
Annual Yield % from dividends1.824.0145%
Returns for 1 year25.6226.9095%
Returns for 3 years-12.373.64-339%
Returns for 5 years-5.5126.84-21%
Returns for 10 years20.2887.2923%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics